14:12 ET Soy Milk Companies on the Radar Screen : The Washington Times reports that a research team from Colorado State University and two other universities found that soy products may stave off baldness, prostate cancer, and even improve troubled skin. The article points to a molecule called equol, which is created in the intestine when soy is digested. A member of the research team said: "These findings are of immense critical importance because blocking the action of the potent androgen D.H.T. has been one of the holy grails of the pharmaceutical industry as a strategy for treating prostate cancer and related disease." Researchers are excited because equol has no side effects, unlike powerful drugs that prevent D.H.T. from being made in the body. While the data mentioned in the article is very early-stage, some stocks that may benefit from positive headlines if this story gains greater prominence include BG, DF, STKL, and HAIN, and to a lesser extent WFMI and UNFI... The stock we think is most likely to attract attention on this news is SunOpta Inc (STKL 10.15 -0.14), which happened to be profiled in IBD yesterday. According to the IBD article, SunOpta's clients include the two largest soy milk companies: DF and HAIN. Co expected to grow earnings 61% this yr and 38% next yr. Mkt-cap $535 mln, float 32 mln, short-interest 9%.
